Michelle A Van Name Selected Research

Michelle A Van Name Research Topics

8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2023 - 01/2017
3	Weight Loss (Weight Reduction) 01/2022 - 07/2016
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 10/2017
2	Insulin Resistance 01/2022 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 10/2017
2	Obesity 01/2016 - 11/2014
1	Body Weight (Weight, Body) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Fatty Liver 01/2020
1	Type 2 Diabetes Mellitus (MODY) 05/2019
1	Hyperglycemia 07/2016
1	Prediabetic State (Prediabetes) 04/2016
1	Weight Gain 01/2016
1	Pediatric Obesity 11/2014

6	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 01/2016
6	Insulin (Novolin)FDA Link 01/2022 - 07/2016
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 10/2017
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2020 - 10/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2020
1	LipidsIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Linoleic Acid (Linoleate)IBA 01/2020
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 05/2019
1	InsulinsIBA 05/2019
1	Sodium-Glucose Transport ProteinsIBA 11/2017
1	SuspensionsIBA 11/2017
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2017
1	Short-Acting InsulinIBA 10/2017
1	pramlintide (Symlin)FDA Link 07/2016
1	Liraglutide FDA Link 07/2016
1	FructoseIBA 01/2016
1	LeptinIBA 11/2014

3	Glycemic Control 01/2018 - 10/2017
2	Therapeutics 05/2019 - 07/2016